Scientific Concept of the National Cohort (status ... - Nationale Kohorte
Scientific Concept of the National Cohort (status ... - Nationale Kohorte
Scientific Concept of the National Cohort (status ... - Nationale Kohorte
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
299<br />
References<br />
207. ATS, ATS Workshop Proceedings: Exhaled nitric oxide and nitric oxide oxidative<br />
metabolism in exhaled breath condensate: Executive summary. Am J Respir Crit<br />
Care Med, 2006. 173(7): p. 811-3.<br />
208. Barnes, P.J., et al., Exhaled nitric oxide in pulmonary diseases: a comprehensive<br />
review. Chest, 2010. 138(3): p. 682-92.<br />
209. Grob, N.M. and A.D. Raed, Exhaled nitric oxide in asthma: progress since <strong>the</strong><br />
introduction <strong>of</strong> standardized methodology. Journal <strong>of</strong> Breath Research, 2008. 2(3):<br />
p. 037002.<br />
210. Merx, H., K.E. Dreinhöfer, and K.P. Gün<strong>the</strong>r, Sozialmedizinische Bedeutung der<br />
Arthrose in Deutschland Socioeconomic Relevance <strong>of</strong> Osteoarthritis in Germany.<br />
Z Orthop Ihre Grenzgeb, 2007. 145: p. 421-429.<br />
211. Thiem, U., et al., Prevalence <strong>of</strong> musculoskeletal complaints and self-reported joint<br />
osteoarthritis in <strong>the</strong> population <strong>of</strong> Herne: a telephone survey. Zeitschrift für<br />
Rheumatologie, 2008. 67(5): p. 432.<br />
212. Schneider, S., et al., Prevalence and correlates <strong>of</strong> osteoarthritis in Germany<br />
Representative data from <strong>the</strong> First <strong>National</strong> Health Survey. . Der Orthopade, 2005.<br />
34(8): p. 782-90.<br />
213. Valdes, A.M. and T.D. Spector, The genetic epidemiology <strong>of</strong> osteoarthritis.<br />
Current opinion in rheumatology, 2010. 22(2): p. 139.<br />
214. Englund, M., et al., Prevalence and incidence <strong>of</strong> rheumatoid arthritis in sou<strong>the</strong>rn<br />
Sweden 2008 and <strong>the</strong>ir relation to prescribed biologics. Rheumatology, 2010.<br />
215. Symmons, D., et al., The prevalence <strong>of</strong> rheumatoid arthritis in <strong>the</strong> United<br />
Kingdom: new estimates for a new century. Rheumatology, 2002. 41(7): p. 793.<br />
216. Woolf, A.D. and B. Pfleger, Burden <strong>of</strong> major musculoskeletal conditions. Bulletin<br />
<strong>of</strong> <strong>the</strong> World Health Organization, 2003. 81: p. 646-656.<br />
217. Zink, A., D. Huscher, and M. Schneider, How closely does rheumatology<br />
treatment follow <strong>the</strong> guidelines?: Ambition and reality. Zeitschrift für<br />
Rheumatologie, 2010.<br />
218. Glaeske, G., C. Schicktanz, and K. Janhsen, GEK-Arzneimittel-Report 2008.<br />
Asgard-Verlag, St. Augustin, 2008.<br />
219. Kramer, H.R. and J.T. Giles, Cardiovascular disease risk in rheumatoid arthritis:<br />
Progress, debate, and opportunity. Arthritis Care & Research, 2010.<br />
220. Scott, D., F. Wolfe, and T.W. Huizinga, Rheumatoid arthritis. Lancet, 2010.<br />
376(9746): p. 1094-108.<br />
221. Solomon, D.H., et al., Patterns <strong>of</strong> cardiovascular risk in rheumatoid arthritis.<br />
Annals <strong>of</strong> <strong>the</strong> rheumatic diseases, 2006. 65(12): p. 1608.<br />
222. Nö<strong>the</strong>n, M. and K. Böhm, Krankheitskosten in Deutschland: Welchen Preis hat<br />
die Gesundheit im Alter?, in Beiträge zur Gesundheitsberichterstattung des<br />
Bundes: Gesundheit und Krankheit im Alter. 2009, Robert-Koch-Institut: Berlin.<br />
223. Picavet, H.S.J. and J. Schouten, Musculoskeletal pain in <strong>the</strong> Ne<strong>the</strong>rlands:<br />
prevalences, consequences and risk groups, <strong>the</strong> DMC3-study. Pain, 2003. 102(1-<br />
2): p. 167-178.<br />
224. Breivik, H., et al., Survey <strong>of</strong> chronic pain in Europe: prevalence, impact on daily<br />
life, and treatment. European Journal <strong>of</strong> Pain, 2006. 10(4): p. 287-333.<br />
C.3